[1] World Health Organization. The top 10 causes of death. 2017. http://www.who.int/mediacenter/factsheets/fs310/en/.
[2] Jain S, Self WH, Wunderic RG,et al. CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among US adults[J].N Engl J Med,2015,373(5): 415-427.
[3] Claessens YE, Debray MP, Tubach F, et al. Early chest computed tomography scan to assist diagnosis and guidetreatment decision for suspected community-acquired pneumonia[J].Am J Respir Crit Care Med,2015,192(8):974-982.
[4] Wunderink RG, Waterer G. Advances in the causes and management of community-acquired pneumonia in adults[J].BMJ,2017,358:2471-2483.
[5] World Health Organization: Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected:Interm Guidance,12 January 2020.
[6] Maskell NA, Batt S,Hedley EL, et al. The bacteriology of pleural infection by genetic and standard methods and its mortality significance[J].Am J Respir Crit Care Med,2006.174(7):817-823.
[7] Petel PE, Bernardo P, Fogarty C, et al. Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia[J].Clin Infect Dis,2008,46(8):1142-1151.
[8] Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adult with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America[J].Am J Respir Crit Care Med,2019;200(7):e45-e47.
[9] Shino Y, Ito R, Kobayashi D, et al. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia[J].Am J Respir Crit Care Med ,2013,188(8):985-995.
[10] Musher DM, Roig IL, Cazares G, et al. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study[J].J Infect,2013,67(1):11-18.
[11] Musher DM, Rueda AM, Kaka AS, et al. The association between pneumococcal pneumonia and acute cardiac events[J].Clin Infect Dis,2007,45(2):158-165.
[12] Guertler C, Wirz B, Christ-Crain M, et al. Inflammatory responses predict long-term mortality risk in community-acquired pneumonia[J].Eur Respir J,2011,37(6):1439-1446.
[13] Lim WS, Rodrigo C, Turner AM, et al. British Thoracic Society. British Thoracic Society community-acquired pneumonia care bundle: results of a national implementation project[J].Thorax,2016,71(3):288-290.
[14] Torres A, Lee N, Cilloniz C, et al. Laboratory diagnosis of pneumonia in the molecular age[J].Eur Respir J,2016,48(6):1764-1778. |
2020, Vol. 37 
